ANI PHARMACEUTICALS INC - Common Stock (ANIP)

CUSIP: 00182C103

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock
Shares outstanding
22,278,088
Total 13F shares
19,278,460
Share change
+400,414
Total reported value
$1,065,666,126
Put/Call ratio
318%
Price per share
$55.28
Number of holders
204
Value change
+$20,364,527
Number of buys
93
Number of sells
90

Security key

00182C103

Report period

Q4 2024

Institutions

204

Top holders

10

Top shareholders of ANIP - ANI PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock, Inc.
13F
Company
12%
2,689,712
$160,468,219 30 Sep 2024
13F
VANGUARD GROUP INC
13F
Company
6.1%
1,348,111
$80,428,302 30 Sep 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
3.2%
716,069
$42,720,677 30 Sep 2024
13F
STATE STREET CORP
13F
Company
3.2%
703,843
$41,991,273 30 Sep 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
2.9%
655,310
$39,094,518 30 Sep 2024
13F
Ranger Investment Management, L.P.
13F
Company
2.6%
589,688
$35,180,786 30 Sep 2024
13F
Pacer Advisors, Inc.
13F
Company
2.6%
568,343
$33,907,343 30 Sep 2024
13F
JPMORGAN CHASE & CO
13F
Company
2.5%
554,835
$33,101,457 30 Sep 2024
13F
Global Alpha Capital Management Ltd.
13F
Company
2.4%
536,450
$32,004,607 30 Sep 2024
13F
CITADEL ADVISORS LLC
13F
Company
2.4%
529,877
$31,612,462 30 Sep 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
2.4%
529,752
$31,605,004 30 Sep 2024
13F
Deep Track Capital, LP
13F
Company
2.3%
504,828
$30,118,038 30 Sep 2024
13F
MACQUARIE GROUP LTD
13F
Company
2.2%
491,647
$29,332,000 30 Sep 2024
13F
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
13F
Company
2.1%
474,828
$28,328,238 30 Sep 2024
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
2%
450,000
$26,847,000 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.9%
425,225
$25,373,296 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
1.8%
401,329
$23,943,361 30 Sep 2024
13F
UBS Group AG
13F
Company
1.3%
286,488
$17,091,875 30 Sep 2024
13F
Soleus Capital Management, L.P.
13F
Company
1.2%
269,000
$16,048,540 30 Sep 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
1.1%
250,346
$14,935,642 30 Sep 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.1%
245,102
$14,622,785 30 Sep 2024
13F
AMERIPRISE FINANCIAL INC
13F
Company
1.1%
237,219
$14,152,484 30 Sep 2024
13F
DEUTSCHE BANK AG\
13F
Company
1%
232,600
$13,876,916 30 Sep 2024
13F
THOMPSON SIEGEL & WALMSLEY LLC
13F
Company
1%
230,159
$13,731,000 30 Sep 2024
13F
BANK OF MONTREAL /CAN/
13F
Company
1%
221,896
$13,043,046 30 Sep 2024
13F
Invesco Ltd.
13F
Company
0.99%
220,359
$13,146,618 30 Sep 2024
13F
NOMURA HOLDINGS INC
13F
Company
0.95%
210,624
$12,565,828 30 Sep 2024
13F
ROYAL BANK OF CANADA
13F
Company
0.94%
210,487
$12,557,000 30 Sep 2024
13F
MIZUHO MARKETS AMERICAS LLC
13F
Company
0.88%
195,613
$11,670,272 30 Sep 2024
13F
KENNEDY CAPITAL MANAGEMENT LLC
13F
Company
0.85%
188,807
$11,264,226 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
0.84%
187,525
$11,187,742 30 Sep 2024
13F
Assenagon Asset Management S.A.
13F
Company
0.84%
186,179
$11,107,439 30 Sep 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.82%
182,028
$10,859,790 30 Sep 2024
13F
LOOMIS SAYLES & CO L P
13F
Company
0.78%
174,617
$10,418,000 30 Sep 2024
13F
Russell Investments Group, Ltd.
13F
Company
0.71%
157,958
$9,423,772 30 Sep 2024
13F
Woodline Partners LP
13F
Company
0.7%
156,488
$9,336,074 30 Sep 2024
13F
BARCLAYS PLC
13F
Company
0.64%
143,033
$8,533,348 30 Sep 2024
13F
Bank of New York Mellon Corp
13F
Company
0.54%
119,428
$7,125,075 30 Sep 2024
13F
D. E. Shaw & Co., Inc.
13F
Company
0.49%
108,621
$6,480,329 30 Sep 2024
13F
Brandywine Global Investment Management, LLC
13F
Company
0.45%
100,899
$5,902,592 30 Sep 2024
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.4%
89,961
$5,367,073 30 Sep 2024
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.39%
87,487
$5,219,474 30 Sep 2024
13F
Qube Research & Technologies Ltd
13F
Company
0.34%
75,705
$4,516,560 30 Sep 2024
13F
GREAT LAKES ADVISORS, LLC
13F
Company
0.32%
70,636
$4,214,144 30 Sep 2024
13F
MARATHON CAPITAL MANAGEMENT
13F
Company
0.31%
70,045
$4,178,885 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.29%
65,576
$3,912,264 30 Sep 2024
13F
F/m Investments LLC
13F
Company
0.28%
61,782
$14,090,808 30 Sep 2024
13F
RICE HALL JAMES & ASSOCIATES, LLC
13F
Company
0.27%
60,375
$3,601,973 30 Sep 2024
13F
WEDGE CAPITAL MANAGEMENT L L P/NC
13F
Company
0.26%
58,682
$3,500,968 30 Sep 2024
13F
Rubric Capital Management LP
13F
Company
0.25%
56,671
$3,380,992 30 Sep 2024
13F

Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock (ANIP) as of Q4 2024

As of 31 Dec 2024, ANI PHARMACEUTICALS INC - Common Stock (ANIP) was held by 204 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,278,460 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, GOLDMAN SACHS GROUP INC, DIMENSIONAL FUND ADVISORS LP, Deep Track Capital, LP, Global Alpha Capital Management Ltd., UBS Group AG, and CITADEL ADVISORS LLC. This page lists 205 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
207
Q4 2024 holders
204
Holder diff
-3
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .